Literature DB >> 11137772

Using the years-of-healthy-life measure to calculate QALYs.

P A Muennig1, M R Gold.   

Abstract

BACKGROUND: The quality-adjusted life year (QALY) is an attractive outcome measure because it captures both health-related quality of life (HRQL) and life expectancy in a single metric. We present a method for calculating QALYs that is simple, utilizes data that are free of charge, and may improve consistency in burden-of-disease investigations.
METHODS: For purposes of illustration, we calculated the burden of disease due to stroke using two abridged life tables, each adjusted for HRQL. The first life table was generated using all-cause mortality and morbidity data (a reference cohort) and the second was generated using all diseases except stroke (a stroke-free cohort). The difference in total QALYs and in quality-adjusted life expectancy (QALE) was determined by subtraction.
RESULTS: Approximately 61,328 (95% CI=60,272, 62,383) QALYs were lost to stroke in the life-table cohort. Stroke is responsible for a decrement of 0.03 years of life expectancy and 0.61 years of QALE in the United States.
CONCLUSIONS: The "years of health life"measure affords a rapid, inexpensive, and sensitive means for estimating the burden of disease for local health priorities and may assist research efforts in including QALYs as an outcome measure.

Entities:  

Mesh:

Year:  2001        PMID: 11137772     DOI: 10.1016/s0749-3797(00)00261-0

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  13 in total

1.  Measuring the health burden of chronic disease and injury using health adjusted life expectancy and the Health Utilities Index.

Authors:  D G Manuel; S E Schultz; J A Kopec
Journal:  J Epidemiol Community Health       Date:  2002-11       Impact factor: 3.710

2.  Predictors of Health Among Refugee Adults from Myanmar and the Development of Their Children.

Authors:  Peter Muennig; Prairie Boulmier-Darden; Noor Khouzam; Wenyi Zhu; Paul Hancock
Journal:  J Immigr Minor Health       Date:  2015-10

3.  US trends in quality-adjusted life expectancy from 1987 to 2008: combining national surveys to more broadly track the health of the nation.

Authors:  Susan T Stewart; David M Cutler; Allison B Rosen
Journal:  Am J Public Health       Date:  2013-09-12       Impact factor: 9.308

4.  Anti-gay prejudice and all-cause mortality among heterosexuals in the United States.

Authors:  Mark L Hatzenbuehler; Anna Bellatorre; Peter Muennig
Journal:  Am J Public Health       Date:  2013-12-12       Impact factor: 9.308

5.  Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom.

Authors:  Oliver Rivero-Arias; Alastair Gray; Jane Wolstenholme
Journal:  Cost Eff Resour Alloc       Date:  2010-04-27

6.  Structural stigma and all-cause mortality in sexual minority populations.

Authors:  Mark L Hatzenbuehler; Anna Bellatorre; Yeonjin Lee; Brian K Finch; Peter Muennig; Kevin Fiscella
Journal:  Soc Sci Med       Date:  2013-06-18       Impact factor: 4.634

7.  Visualization and dynamics of multidimensional health-related quality-of-life-adjusted overall survival: a new analytic approach.

Authors:  Adin-Cristian Andrei; Kathleen L Grady
Journal:  Qual Life Res       Date:  2014-01-07       Impact factor: 4.147

8.  Deteriorating health status in Stockholm 1998-2002: results from repeated population surveys using the EQ-5D.

Authors:  Kristina Burström; Magnus Johannesson; Clas Rehnberg
Journal:  Qual Life Res       Date:  2007-09-09       Impact factor: 4.147

9.  Quality-adjusted life-years and helmet use among motorcyclists sustaining head injuries.

Authors:  Hsin-Yi Lee; Yeh-Hsin Chen; Wen-Ta Chiu; Jing-Shiang Hwang; Jung-Der Wang
Journal:  Am J Public Health       Date:  2010-01       Impact factor: 9.308

10.  Racial disparities in quality-adjusted life-years associated with diabetes and visual impairment.

Authors:  Kathryn E McCollister; D Diane Zheng; Cristina A Fernandez; David J Lee; Byron L Lam; Kristopher L Arheart; Anat Galor; Manuel Ocasio; Peter Muennig
Journal:  Diabetes Care       Date:  2012-06-29       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.